Seeking Alpha

Takeda Pharmaceutical (TKPYY.PK) buys privately-held URL Pharma for $800M in a deal that could...

Takeda Pharmaceutical (TKPYY.PK) buys privately-held URL Pharma for $800M in a deal that could include performance payments down the road. URL's major product is gout treatment Colcrys.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|